FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20240705E00388
1. Date of relevant event: 03/07/2024
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 02190
4. Name of listed corporation: 歸創通橋醫療科技股份有限公司 - B - H股 
5. Class of shares: H Shares 
6. Number of issued shares in class: 324,619,744
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) XIE
(Other names) YANG
10. Name of director (Chinese): 谢阳 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1213The number of shares in which you are interested has reduced because:
any other event (you must briefly describe the relevant event in the Supplementary Information box)
 
 
2501Other (you must describe the capacity in the Supplementary Information box)
 
2,360,007  HKD      12.0000 
3101Cash
 
Short position 
 
 
 
           
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position14,651,4254.51
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position12,291,4183.79
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2201Interest of corporation controlled by you
Long position11,891,418
2101Beneficial owner
Long position400,000
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
           
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
珠海通桥投资中心(有限合伙)珠海市横琴新区环岛东路1889号21栋411室15卡位谢阳36.36Y
Long position8,141,222
杭州涪江投资合伙企业(有限合伙)浙江省杭州市余杭区仓前街道数云路270号B座6层603室谢阳51.54Y
Long position3,750,196
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
  
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: 表格24及27:珠海通桥投资中心(有限合伙)、杭州涪江投资合伙企业(有限合伙)于2024年7月3日分别减持995,558、1,364,449股H股(注:谢阳在珠海通桥投资中心(有限合伙)持有40.00%的经济利益及在杭州涪江投资合伙企业(有限合伙)持有49.30%的经济利益,珠海通桥及杭州涪江均为僱员激励平台,因此,谢阳被视为通过珠海通桥于8,141,222股H股中及通过杭州涪江于3,750,196股H股中拥有权益,但谢阳并非此等平台涉及的一致行动协议的一致行动人。)
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 05/07/2024
(dd/mm/yyyy)